Entertainment news, movies, and celebrities
Kyverna's recent study shows promising, enduring autoimmune relief from its cell therapy, signaling a significant advancement in treatment options.
Heidi Overton's Senate hearing as FDA commissioner nominee underscores urgency in drug approvals, while states weigh Medicaid pricing choices.
Insurers are opposing Medicare's new proposal that alters how remote patient monitoring services are delivered, raising concerns over patient care management.
The U.S. faces its most significant measles outbreak in over three decades, with unvaccinated individuals suffering the worst consequences.
Radiology is evolving as practices actively adopt AI technologies to enhance services and attract talent, moving beyond fears of obsolescence.
Eli Lilly's latest breast cancer therapy has gained FDA approval, paving the way for enhanced treatment options in oncology.
Novo Nordisk outlines its strategy to broaden its pipeline, while Alkermes reveals hopeful ADHD treatment data, indicating potential new markets.
Alkermes' Phase 1 trial of ALKS 7290, designed for sleep disorders, indicates potential effectiveness for ADHD with significant symptom reduction.
Novo Nordisk aims to broaden its product pipeline beyond diabetes, targeting revenue growth with a focus on consumer-friendly approaches by 2030.
Zach Lahn, GOP candidate for Iowa governor, is leveraging RFK Jr.'s support amidst a challenging race against a Democratic opponent.
Addiction clinics report a sharp rise in patients seeking help for kratom and 7-OH dependence amid growing warnings about these substances.
Recognizing the alcohol flush reaction is vital for East Asian communities; medical professionals play a key role in patient education about its risks.
A geriatrician emphasizes the need for caution in utilizing AI predictions for older patients, noting potential impacts on care decisions.
Robert F. Kennedy Jr. introduces a new initiative to expedite autism diagnoses while addressing challenges in current methodologies.
Kennedy reinforced his anti-vaccine advocacy during a pivotal speech at a Children’s Health Defense conference, highlighting its significance ahead of upcoming elections.
The FDA has approved Fayuvi, the first gene therapy for Sanfilippo syndrome, offering hope to affected families and changing treatment dynamics.
Drugmakers are investigating the use of obesity treatments in children as young as six, reflecting a shift in pediatric health approaches.
GSK has secured global rights to a novel multiple myeloma treatment from China's Chimagen Biosciences, enhancing its pipeline with a $750 million investment.
Recent documents highlight significant issues with Medicare's prior-authorization pilot, raising questions about its effectiveness and future rollout.
Trutakna effectively stabilized kidney function and reduced risks in patients with IgA nephropathy, prompting Vera to seek full FDA approval.